Full Length ArticleThe role of von Willebrand factor in primary haemostasis under conditions of haemodilution

- Binding of VWF to collagen type III and VWF-mediated platelet adhesion decreases with the diminution in haematocrit
- Increasing VWF concentration improves platelet adhesion under low haematocrit conditions and variable platelet counts
- All VWF multimer-sizes bind equally well to collagen III under high physiological shear stress conditions (31.59 - 54.63 dyn/cm2)
- At low shear stress of 21.41 dyn/cm2 the binding of high molecular weight multimers (> 10) is favoured

IntroductionSevere blood loss and related haemodilution during cardiac surgery result in a reduced platelet count which may lead to impaired primary haemostasis. Additionally, the reduced haematocrit lowers rheological forces in circulation and may account for lowered platelet adhesiveness and potentially reduced von Willebrand factor (VWF) activity. These mechanisms may lead to postoperative bleeding. Aim of this study was the examination of VWF activity and VWF-mediated platelet adhesion to collagen under conditions of haemodilution.Materials and methodsAn in vitro flow chamber was utilized to examine the primary haemostasis under a high arterial shear rate of 1500 s− 1 at variable VWF concentrations, platelet counts and haematocrit levels.ResultsUnder a high arterial shear rate, VWF activity is highly dependent on blood viscosity. Both VWF-collagen binding and VWF-mediated platelet adhesion to collagen were significantly increased with increasing haematocrit. Interestingly, we found slight differences in the VWF multimer sizes able to bind collagen under different shear stress conditions. Under conditions of haemodilution, platelet adhesion was strongly dependent on VWF concentration. Increasing VWF concentration improved platelet adhesiveness under low haematocrit conditions (30%) and variable platelet counts (80, 150 and 250 × 109/L). This effect was nearly abolished at very low platelet count levels of 50 × 109/L.ConclusionsVWF improves platelet function under conditions of haemodilution. Therefore, increasing VWF concentration may represent a complementary strategy to administration of platelet concentrates for the management of bleeding in thrombocytopenia.